nodes	percent_of_prediction	percent_of_DWPC	metapath
Orciprenaline—asthma—chronic obstructive pulmonary disease	0.21	1	CtDrD
Orciprenaline—Adrenergic beta2-Agonists—Arformoterol—chronic obstructive pulmonary disease	0.124	0.333	CiPCiCtD
Orciprenaline—Adrenergic beta2-Agonists—Formoterol—chronic obstructive pulmonary disease	0.124	0.333	CiPCiCtD
Orciprenaline—Adrenergic beta2-Agonists—Salbutamol—chronic obstructive pulmonary disease	0.124	0.333	CiPCiCtD
Orciprenaline—ADRB2—chronic obstructive pulmonary disease	0.117	1	CbGaD
Orciprenaline—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0481	0.398	CbGbCtD
Orciprenaline—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0365	0.301	CbGbCtD
Orciprenaline—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0365	0.301	CbGbCtD
Orciprenaline—Fenoterol—Arformoterol—chronic obstructive pulmonary disease	0.0235	0.152	CrCrCtD
Orciprenaline—Fenoterol—Formoterol—chronic obstructive pulmonary disease	0.0235	0.152	CrCrCtD
Orciprenaline—Phenylephrine—Salbutamol—chronic obstructive pulmonary disease	0.0209	0.135	CrCrCtD
Orciprenaline—Terbutaline—Salbutamol—chronic obstructive pulmonary disease	0.0192	0.124	CrCrCtD
Orciprenaline—Isoetarine—Salbutamol—chronic obstructive pulmonary disease	0.0178	0.115	CrCrCtD
Orciprenaline—Isoprenaline—Arformoterol—chronic obstructive pulmonary disease	0.0135	0.0872	CrCrCtD
Orciprenaline—Isoprenaline—Formoterol—chronic obstructive pulmonary disease	0.0135	0.0872	CrCrCtD
Orciprenaline—Epinephrine—Salbutamol—chronic obstructive pulmonary disease	0.0126	0.0813	CrCrCtD
Orciprenaline—Isoprenaline—Salbutamol—chronic obstructive pulmonary disease	0.0102	0.0661	CrCrCtD
Orciprenaline—Tremor fine—Salbutamol—chronic obstructive pulmonary disease	0.00392	0.164	CcSEcCtD
Orciprenaline—Exacerbation of asthma—Arformoterol—chronic obstructive pulmonary disease	0.000761	0.0318	CcSEcCtD
Orciprenaline—Exacerbation of asthma—Formoterol—chronic obstructive pulmonary disease	0.000761	0.0318	CcSEcCtD
Orciprenaline—Exacerbation of asthma—Salbutamol—chronic obstructive pulmonary disease	0.000718	0.0301	CcSEcCtD
Orciprenaline—Influenza—Roflumilast—chronic obstructive pulmonary disease	0.000246	0.0103	CcSEcCtD
Orciprenaline—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.000196	0.00819	CcSEcCtD
Orciprenaline—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.000172	0.00721	CcSEcCtD
Orciprenaline—Tension—Roflumilast—chronic obstructive pulmonary disease	0.000168	0.00703	CcSEcCtD
Orciprenaline—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.000168	0.00701	CcSEcCtD
Orciprenaline—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.000166	0.00695	CcSEcCtD
Orciprenaline—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.000164	0.00688	CcSEcCtD
Orciprenaline—Terbutaline—ADRB2—chronic obstructive pulmonary disease	0.000162	0.165	CrCbGaD
Orciprenaline—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00016	0.00671	CcSEcCtD
Orciprenaline—Isoetarine—ADRB2—chronic obstructive pulmonary disease	0.000156	0.159	CrCbGaD
Orciprenaline—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000151	0.00633	CcSEcCtD
Orciprenaline—Sotalol—ADRB2—chronic obstructive pulmonary disease	0.000151	0.154	CrCbGaD
Orciprenaline—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.000146	0.0061	CcSEcCtD
Orciprenaline—Fenoterol—ADRB2—chronic obstructive pulmonary disease	0.000133	0.135	CrCbGaD
Orciprenaline—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.00549	CcSEcCtD
Orciprenaline—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.000131	0.00549	CcSEcCtD
Orciprenaline—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.00543	CcSEcCtD
Orciprenaline—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.00013	0.00543	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000127	0.00532	CcSEcCtD
Orciprenaline—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.000127	0.00532	CcSEcCtD
Orciprenaline—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000126	0.00528	CcSEcCtD
Orciprenaline—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00521	CcSEcCtD
Orciprenaline—Asthma—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00521	CcSEcCtD
Orciprenaline—Influenza—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00521	CcSEcCtD
Orciprenaline—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00521	CcSEcCtD
Orciprenaline—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.00518	CcSEcCtD
Orciprenaline—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.00513	CcSEcCtD
Orciprenaline—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00513	CcSEcCtD
Orciprenaline—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00513	CcSEcCtD
Orciprenaline—Influenza—Montelukast—chronic obstructive pulmonary disease	0.000122	0.00511	CcSEcCtD
Orciprenaline—Asthma—Montelukast—chronic obstructive pulmonary disease	0.000122	0.00511	CcSEcCtD
Orciprenaline—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00012	0.00504	CcSEcCtD
Orciprenaline—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.00492	CcSEcCtD
Orciprenaline—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.00492	CcSEcCtD
Orciprenaline—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000117	0.0049	CcSEcCtD
Orciprenaline—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00484	CcSEcCtD
Orciprenaline—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.0048	CcSEcCtD
Orciprenaline—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000112	0.00468	CcSEcCtD
Orciprenaline—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000111	0.00464	CcSEcCtD
Orciprenaline—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000111	0.00464	CcSEcCtD
Orciprenaline—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.00011	0.00462	CcSEcCtD
Orciprenaline—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000109	0.00455	CcSEcCtD
Orciprenaline—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000107	0.00447	CcSEcCtD
Orciprenaline—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.00439	CcSEcCtD
Orciprenaline—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000103	0.0043	CcSEcCtD
Orciprenaline—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000101	0.00424	CcSEcCtD
Orciprenaline—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000101	0.00422	CcSEcCtD
Orciprenaline—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.00421	CcSEcCtD
Orciprenaline—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.0001	0.00419	CcSEcCtD
Orciprenaline—Phenylephrine—CYP1A2—chronic obstructive pulmonary disease	9.71e-05	0.0989	CrCbGaD
Orciprenaline—Syncope—Tiotropium—chronic obstructive pulmonary disease	9.65e-05	0.00404	CcSEcCtD
Orciprenaline—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	9.55e-05	0.004	CcSEcCtD
Orciprenaline—Palpitations—Tiotropium—chronic obstructive pulmonary disease	9.51e-05	0.00398	CcSEcCtD
Orciprenaline—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	9.46e-05	0.00396	CcSEcCtD
Orciprenaline—Cough—Tiotropium—chronic obstructive pulmonary disease	9.39e-05	0.00393	CcSEcCtD
Orciprenaline—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	9.31e-05	0.0039	CcSEcCtD
Orciprenaline—Hypertension—Tiotropium—chronic obstructive pulmonary disease	9.29e-05	0.00389	CcSEcCtD
Orciprenaline—Dizziness—Roflumilast—chronic obstructive pulmonary disease	9.23e-05	0.00386	CcSEcCtD
Orciprenaline—Shock—Aminophylline—chronic obstructive pulmonary disease	9.16e-05	0.00383	CcSEcCtD
Orciprenaline—Myalgia—Tiotropium—chronic obstructive pulmonary disease	9.16e-05	0.00383	CcSEcCtD
Orciprenaline—Chest pain—Tiotropium—chronic obstructive pulmonary disease	9.16e-05	0.00383	CcSEcCtD
Orciprenaline—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	9.09e-05	0.0038	CcSEcCtD
Orciprenaline—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	8.96e-05	0.00375	CcSEcCtD
Orciprenaline—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	8.91e-05	0.00373	CcSEcCtD
Orciprenaline—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	8.91e-05	0.00373	CcSEcCtD
Orciprenaline—Vomiting—Roflumilast—chronic obstructive pulmonary disease	8.88e-05	0.00372	CcSEcCtD
Orciprenaline—Oedema—Tiotropium—chronic obstructive pulmonary disease	8.78e-05	0.00367	CcSEcCtD
Orciprenaline—Headache—Roflumilast—chronic obstructive pulmonary disease	8.75e-05	0.00366	CcSEcCtD
Orciprenaline—Shock—Tiotropium—chronic obstructive pulmonary disease	8.64e-05	0.00362	CcSEcCtD
Orciprenaline—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	8.57e-05	0.00359	CcSEcCtD
Orciprenaline—Tension—Arformoterol—chronic obstructive pulmonary disease	8.52e-05	0.00357	CcSEcCtD
Orciprenaline—Tension—Formoterol—chronic obstructive pulmonary disease	8.52e-05	0.00357	CcSEcCtD
Orciprenaline—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	8.5e-05	0.00356	CcSEcCtD
Orciprenaline—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	8.5e-05	0.00356	CcSEcCtD
Orciprenaline—Chills—Salbutamol—chronic obstructive pulmonary disease	8.45e-05	0.00354	CcSEcCtD
Orciprenaline—Nervousness—Formoterol—chronic obstructive pulmonary disease	8.43e-05	0.00353	CcSEcCtD
Orciprenaline—Nervousness—Arformoterol—chronic obstructive pulmonary disease	8.43e-05	0.00353	CcSEcCtD
Orciprenaline—Insomnia—Aminophylline—chronic obstructive pulmonary disease	8.42e-05	0.00352	CcSEcCtD
Orciprenaline—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	8.41e-05	0.00352	CcSEcCtD
Orciprenaline—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	8.35e-05	0.00349	CcSEcCtD
Orciprenaline—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	8.35e-05	0.00349	CcSEcCtD
Orciprenaline—Nausea—Roflumilast—chronic obstructive pulmonary disease	8.29e-05	0.00347	CcSEcCtD
Orciprenaline—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	8.18e-05	0.00342	CcSEcCtD
Orciprenaline—Tremor—Formoterol—chronic obstructive pulmonary disease	8.13e-05	0.0034	CcSEcCtD
Orciprenaline—Tremor—Arformoterol—chronic obstructive pulmonary disease	8.13e-05	0.0034	CcSEcCtD
Orciprenaline—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	8.07e-05	0.00338	CcSEcCtD
Orciprenaline—Tension—Salbutamol—chronic obstructive pulmonary disease	8.04e-05	0.00337	CcSEcCtD
Orciprenaline—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	8.03e-05	0.00336	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	8e-05	0.00335	CcSEcCtD
Orciprenaline—Tremor—Montelukast—chronic obstructive pulmonary disease	7.97e-05	0.00333	CcSEcCtD
Orciprenaline—Nervousness—Salbutamol—chronic obstructive pulmonary disease	7.96e-05	0.00333	CcSEcCtD
Orciprenaline—Insomnia—Tiotropium—chronic obstructive pulmonary disease	7.94e-05	0.00332	CcSEcCtD
Orciprenaline—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	7.88e-05	0.0033	CcSEcCtD
Orciprenaline—Tremor—Salbutamol—chronic obstructive pulmonary disease	7.68e-05	0.00321	CcSEcCtD
Orciprenaline—Palpitations—Formoterol—chronic obstructive pulmonary disease	7.67e-05	0.00321	CcSEcCtD
Orciprenaline—Palpitations—Arformoterol—chronic obstructive pulmonary disease	7.67e-05	0.00321	CcSEcCtD
Orciprenaline—Cough—Arformoterol—chronic obstructive pulmonary disease	7.58e-05	0.00317	CcSEcCtD
Orciprenaline—Cough—Formoterol—chronic obstructive pulmonary disease	7.58e-05	0.00317	CcSEcCtD
Orciprenaline—Palpitations—Montelukast—chronic obstructive pulmonary disease	7.51e-05	0.00315	CcSEcCtD
Orciprenaline—Hypertension—Arformoterol—chronic obstructive pulmonary disease	7.5e-05	0.00314	CcSEcCtD
Orciprenaline—Hypertension—Formoterol—chronic obstructive pulmonary disease	7.5e-05	0.00314	CcSEcCtD
Orciprenaline—Cough—Montelukast—chronic obstructive pulmonary disease	7.42e-05	0.00311	CcSEcCtD
Orciprenaline—Urticaria—Aminophylline—chronic obstructive pulmonary disease	7.4e-05	0.0031	CcSEcCtD
Orciprenaline—Chest pain—Arformoterol—chronic obstructive pulmonary disease	7.39e-05	0.00309	CcSEcCtD
Orciprenaline—Myalgia—Arformoterol—chronic obstructive pulmonary disease	7.39e-05	0.00309	CcSEcCtD
Orciprenaline—Myalgia—Formoterol—chronic obstructive pulmonary disease	7.39e-05	0.00309	CcSEcCtD
Orciprenaline—Chest pain—Formoterol—chronic obstructive pulmonary disease	7.39e-05	0.00309	CcSEcCtD
Orciprenaline—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	7.36e-05	0.00308	CcSEcCtD
Orciprenaline—Syncope—Salbutamol—chronic obstructive pulmonary disease	7.35e-05	0.00308	CcSEcCtD
Orciprenaline—Palpitations—Salbutamol—chronic obstructive pulmonary disease	7.24e-05	0.00303	CcSEcCtD
Orciprenaline—Myalgia—Montelukast—chronic obstructive pulmonary disease	7.24e-05	0.00303	CcSEcCtD
Orciprenaline—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	7.23e-05	0.00303	CcSEcCtD
Orciprenaline—Dry mouth—Formoterol—chronic obstructive pulmonary disease	7.23e-05	0.00303	CcSEcCtD
Orciprenaline—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	7.21e-05	0.00302	CcSEcCtD
Orciprenaline—Cough—Salbutamol—chronic obstructive pulmonary disease	7.15e-05	0.00299	CcSEcCtD
Orciprenaline—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	7.09e-05	0.00297	CcSEcCtD
Orciprenaline—Oedema—Formoterol—chronic obstructive pulmonary disease	7.09e-05	0.00297	CcSEcCtD
Orciprenaline—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	7.09e-05	0.00297	CcSEcCtD
Orciprenaline—Oedema—Arformoterol—chronic obstructive pulmonary disease	7.09e-05	0.00297	CcSEcCtD
Orciprenaline—Hypertension—Salbutamol—chronic obstructive pulmonary disease	7.08e-05	0.00296	CcSEcCtD
Orciprenaline—Myalgia—Salbutamol—chronic obstructive pulmonary disease	6.98e-05	0.00292	CcSEcCtD
Orciprenaline—Chest pain—Salbutamol—chronic obstructive pulmonary disease	6.98e-05	0.00292	CcSEcCtD
Orciprenaline—Urticaria—Tiotropium—chronic obstructive pulmonary disease	6.97e-05	0.00292	CcSEcCtD
Orciprenaline—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	6.94e-05	0.0029	CcSEcCtD
Orciprenaline—Oedema—Montelukast—chronic obstructive pulmonary disease	6.94e-05	0.0029	CcSEcCtD
Orciprenaline—Tachycardia—Formoterol—chronic obstructive pulmonary disease	6.92e-05	0.00289	CcSEcCtD
Orciprenaline—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	6.92e-05	0.00289	CcSEcCtD
Orciprenaline—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	6.86e-05	0.00287	CcSEcCtD
Orciprenaline—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	6.83e-05	0.00286	CcSEcCtD
Orciprenaline—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	6.69e-05	0.0028	CcSEcCtD
Orciprenaline—Oedema—Salbutamol—chronic obstructive pulmonary disease	6.69e-05	0.0028	CcSEcCtD
Orciprenaline—Pruritus—Aminophylline—chronic obstructive pulmonary disease	6.59e-05	0.00276	CcSEcCtD
Orciprenaline—Shock—Salbutamol—chronic obstructive pulmonary disease	6.58e-05	0.00275	CcSEcCtD
Orciprenaline—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	6.57e-05	0.00275	CcSEcCtD
Orciprenaline—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	6.53e-05	0.00273	CcSEcCtD
Orciprenaline—Isoprenaline—ADRB2—chronic obstructive pulmonary disease	6.49e-05	0.0662	CrCbGaD
Orciprenaline—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	6.47e-05	0.00271	CcSEcCtD
Orciprenaline—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	6.47e-05	0.00271	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	6.46e-05	0.0027	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	6.46e-05	0.0027	CcSEcCtD
Orciprenaline—Insomnia—Arformoterol—chronic obstructive pulmonary disease	6.41e-05	0.00268	CcSEcCtD
Orciprenaline—Insomnia—Formoterol—chronic obstructive pulmonary disease	6.41e-05	0.00268	CcSEcCtD
Orciprenaline—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	6.37e-05	0.00267	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	6.32e-05	0.00265	CcSEcCtD
Orciprenaline—Somnolence—Arformoterol—chronic obstructive pulmonary disease	6.3e-05	0.00264	CcSEcCtD
Orciprenaline—Somnolence—Formoterol—chronic obstructive pulmonary disease	6.3e-05	0.00264	CcSEcCtD
Orciprenaline—Insomnia—Montelukast—chronic obstructive pulmonary disease	6.28e-05	0.00263	CcSEcCtD
Orciprenaline—Pruritus—Tiotropium—chronic obstructive pulmonary disease	6.21e-05	0.0026	CcSEcCtD
Orciprenaline—Somnolence—Montelukast—chronic obstructive pulmonary disease	6.17e-05	0.00258	CcSEcCtD
Orciprenaline—Dizziness—Aminophylline—chronic obstructive pulmonary disease	6.16e-05	0.00258	CcSEcCtD
Orciprenaline—Epinephrine—TNF—chronic obstructive pulmonary disease	6.16e-05	0.0627	CrCbGaD
Orciprenaline—Fatigue—Arformoterol—chronic obstructive pulmonary disease	6.11e-05	0.00256	CcSEcCtD
Orciprenaline—Fatigue—Formoterol—chronic obstructive pulmonary disease	6.11e-05	0.00256	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	6.1e-05	0.00255	CcSEcCtD
Orciprenaline—Pain—Formoterol—chronic obstructive pulmonary disease	6.06e-05	0.00254	CcSEcCtD
Orciprenaline—Pain—Arformoterol—chronic obstructive pulmonary disease	6.06e-05	0.00254	CcSEcCtD
Orciprenaline—Insomnia—Salbutamol—chronic obstructive pulmonary disease	6.05e-05	0.00253	CcSEcCtD
Orciprenaline—Fatigue—Montelukast—chronic obstructive pulmonary disease	5.98e-05	0.0025	CcSEcCtD
Orciprenaline—Somnolence—Salbutamol—chronic obstructive pulmonary disease	5.95e-05	0.00249	CcSEcCtD
Orciprenaline—Pain—Montelukast—chronic obstructive pulmonary disease	5.93e-05	0.00248	CcSEcCtD
Orciprenaline—Vomiting—Aminophylline—chronic obstructive pulmonary disease	5.92e-05	0.00248	CcSEcCtD
Orciprenaline—Headache—Aminophylline—chronic obstructive pulmonary disease	5.83e-05	0.00244	CcSEcCtD
Orciprenaline—Dizziness—Tiotropium—chronic obstructive pulmonary disease	5.81e-05	0.00243	CcSEcCtD
Orciprenaline—Fatigue—Salbutamol—chronic obstructive pulmonary disease	5.77e-05	0.00241	CcSEcCtD
Orciprenaline—Pain—Salbutamol—chronic obstructive pulmonary disease	5.72e-05	0.00239	CcSEcCtD
Orciprenaline—Urticaria—Formoterol—chronic obstructive pulmonary disease	5.63e-05	0.00236	CcSEcCtD
Orciprenaline—Urticaria—Arformoterol—chronic obstructive pulmonary disease	5.63e-05	0.00236	CcSEcCtD
Orciprenaline—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	5.6e-05	0.00234	CcSEcCtD
Orciprenaline—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	5.6e-05	0.00234	CcSEcCtD
Orciprenaline—Vomiting—Tiotropium—chronic obstructive pulmonary disease	5.58e-05	0.00234	CcSEcCtD
Orciprenaline—Isoprenaline—CYP1A1—chronic obstructive pulmonary disease	5.57e-05	0.0567	CrCbGaD
Orciprenaline—Nausea—Aminophylline—chronic obstructive pulmonary disease	5.53e-05	0.00231	CcSEcCtD
Orciprenaline—Urticaria—Montelukast—chronic obstructive pulmonary disease	5.51e-05	0.00231	CcSEcCtD
Orciprenaline—Headache—Tiotropium—chronic obstructive pulmonary disease	5.5e-05	0.0023	CcSEcCtD
Orciprenaline—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	5.49e-05	0.0023	CcSEcCtD
Orciprenaline—Epinephrine—ADRB2—chronic obstructive pulmonary disease	5.46e-05	0.0556	CrCbGaD
Orciprenaline—Urticaria—Salbutamol—chronic obstructive pulmonary disease	5.32e-05	0.00222	CcSEcCtD
Orciprenaline—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	5.29e-05	0.00221	CcSEcCtD
Orciprenaline—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	5.22e-05	0.00218	CcSEcCtD
Orciprenaline—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	5.22e-05	0.00218	CcSEcCtD
Orciprenaline—Nausea—Tiotropium—chronic obstructive pulmonary disease	5.22e-05	0.00218	CcSEcCtD
Orciprenaline—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	5.16e-05	0.00216	CcSEcCtD
Orciprenaline—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	5.11e-05	0.00214	CcSEcCtD
Orciprenaline—Asthenia—Arformoterol—chronic obstructive pulmonary disease	5.08e-05	0.00213	CcSEcCtD
Orciprenaline—Asthenia—Formoterol—chronic obstructive pulmonary disease	5.08e-05	0.00213	CcSEcCtD
Orciprenaline—Pruritus—Formoterol—chronic obstructive pulmonary disease	5.01e-05	0.0021	CcSEcCtD
Orciprenaline—Pruritus—Arformoterol—chronic obstructive pulmonary disease	5.01e-05	0.0021	CcSEcCtD
Orciprenaline—Asthenia—Montelukast—chronic obstructive pulmonary disease	4.98e-05	0.00208	CcSEcCtD
Orciprenaline—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	4.93e-05	0.00206	CcSEcCtD
Orciprenaline—Pruritus—Montelukast—chronic obstructive pulmonary disease	4.91e-05	0.00206	CcSEcCtD
Orciprenaline—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	4.85e-05	0.00203	CcSEcCtD
Orciprenaline—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	4.85e-05	0.00203	CcSEcCtD
Orciprenaline—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	4.83e-05	0.00202	CcSEcCtD
Orciprenaline—Asthenia—Salbutamol—chronic obstructive pulmonary disease	4.8e-05	0.00201	CcSEcCtD
Orciprenaline—Sweating increased—Prednisone—chronic obstructive pulmonary disease	4.78e-05	0.002	CcSEcCtD
Orciprenaline—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	4.75e-05	0.00199	CcSEcCtD
Orciprenaline—Pruritus—Salbutamol—chronic obstructive pulmonary disease	4.73e-05	0.00198	CcSEcCtD
Orciprenaline—Dizziness—Formoterol—chronic obstructive pulmonary disease	4.69e-05	0.00196	CcSEcCtD
Orciprenaline—Dizziness—Arformoterol—chronic obstructive pulmonary disease	4.69e-05	0.00196	CcSEcCtD
Orciprenaline—Dizziness—Montelukast—chronic obstructive pulmonary disease	4.59e-05	0.00192	CcSEcCtD
Orciprenaline—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	4.58e-05	0.00192	CcSEcCtD
Orciprenaline—Epinephrine—CYP1A2—chronic obstructive pulmonary disease	4.51e-05	0.046	CrCbGaD
Orciprenaline—Vomiting—Formoterol—chronic obstructive pulmonary disease	4.51e-05	0.00189	CcSEcCtD
Orciprenaline—Vomiting—Arformoterol—chronic obstructive pulmonary disease	4.51e-05	0.00189	CcSEcCtD
Orciprenaline—Headache—Formoterol—chronic obstructive pulmonary disease	4.44e-05	0.00186	CcSEcCtD
Orciprenaline—Headache—Arformoterol—chronic obstructive pulmonary disease	4.44e-05	0.00186	CcSEcCtD
Orciprenaline—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	4.43e-05	0.00185	CcSEcCtD
Orciprenaline—Dizziness—Salbutamol—chronic obstructive pulmonary disease	4.42e-05	0.00185	CcSEcCtD
Orciprenaline—Vomiting—Montelukast—chronic obstructive pulmonary disease	4.41e-05	0.00185	CcSEcCtD
Orciprenaline—Headache—Montelukast—chronic obstructive pulmonary disease	4.35e-05	0.00182	CcSEcCtD
Orciprenaline—Vomiting—Salbutamol—chronic obstructive pulmonary disease	4.25e-05	0.00178	CcSEcCtD
Orciprenaline—Syncope—Prednisolone—chronic obstructive pulmonary disease	4.22e-05	0.00176	CcSEcCtD
Orciprenaline—Nausea—Arformoterol—chronic obstructive pulmonary disease	4.21e-05	0.00176	CcSEcCtD
Orciprenaline—Nausea—Formoterol—chronic obstructive pulmonary disease	4.21e-05	0.00176	CcSEcCtD
Orciprenaline—Headache—Salbutamol—chronic obstructive pulmonary disease	4.19e-05	0.00175	CcSEcCtD
Orciprenaline—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	4.13e-05	0.00173	CcSEcCtD
Orciprenaline—Nausea—Montelukast—chronic obstructive pulmonary disease	4.12e-05	0.00173	CcSEcCtD
Orciprenaline—Hypertension—Prednisolone—chronic obstructive pulmonary disease	4.06e-05	0.0017	CcSEcCtD
Orciprenaline—Nausea—Salbutamol—chronic obstructive pulmonary disease	3.97e-05	0.00166	CcSEcCtD
Orciprenaline—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	3.84e-05	0.00161	CcSEcCtD
Orciprenaline—Oedema—Prednisolone—chronic obstructive pulmonary disease	3.84e-05	0.00161	CcSEcCtD
Orciprenaline—Shock—Prednisolone—chronic obstructive pulmonary disease	3.78e-05	0.00158	CcSEcCtD
Orciprenaline—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	3.75e-05	0.00157	CcSEcCtD
Orciprenaline—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	3.71e-05	0.00155	CcSEcCtD
Orciprenaline—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	3.51e-05	0.00147	CcSEcCtD
Orciprenaline—Insomnia—Prednisolone—chronic obstructive pulmonary disease	3.47e-05	0.00145	CcSEcCtD
Orciprenaline—Pain—Prednisolone—chronic obstructive pulmonary disease	3.28e-05	0.00137	CcSEcCtD
Orciprenaline—Vision blurred—Prednisone—chronic obstructive pulmonary disease	3.22e-05	0.00135	CcSEcCtD
Orciprenaline—Syncope—Prednisone—chronic obstructive pulmonary disease	3.06e-05	0.00128	CcSEcCtD
Orciprenaline—Urticaria—Prednisolone—chronic obstructive pulmonary disease	3.05e-05	0.00128	CcSEcCtD
Orciprenaline—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	3e-05	0.00126	CcSEcCtD
Orciprenaline—Hypertension—Prednisone—chronic obstructive pulmonary disease	2.95e-05	0.00123	CcSEcCtD
Orciprenaline—Myalgia—Prednisone—chronic obstructive pulmonary disease	2.91e-05	0.00122	CcSEcCtD
Orciprenaline—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	2.83e-05	0.00118	CcSEcCtD
Orciprenaline—Oedema—Prednisone—chronic obstructive pulmonary disease	2.79e-05	0.00117	CcSEcCtD
Orciprenaline—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	2.79e-05	0.00117	CcSEcCtD
Orciprenaline—Shock—Prednisone—chronic obstructive pulmonary disease	2.74e-05	0.00115	CcSEcCtD
Orciprenaline—Tachycardia—Prednisone—chronic obstructive pulmonary disease	2.72e-05	0.00114	CcSEcCtD
Orciprenaline—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	2.7e-05	0.00113	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	2.54e-05	0.00106	CcSEcCtD
Orciprenaline—Dizziness—Prednisolone—chronic obstructive pulmonary disease	2.54e-05	0.00106	CcSEcCtD
Orciprenaline—Insomnia—Prednisone—chronic obstructive pulmonary disease	2.52e-05	0.00106	CcSEcCtD
Orciprenaline—Fatigue—Prednisone—chronic obstructive pulmonary disease	2.4e-05	0.00101	CcSEcCtD
Orciprenaline—Headache—Prednisolone—chronic obstructive pulmonary disease	2.4e-05	0.00101	CcSEcCtD
Orciprenaline—Nausea—Prednisolone—chronic obstructive pulmonary disease	2.28e-05	0.000954	CcSEcCtD
Orciprenaline—Urticaria—Prednisone—chronic obstructive pulmonary disease	2.22e-05	0.000927	CcSEcCtD
Orciprenaline—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	2.2e-05	0.000923	CcSEcCtD
Orciprenaline—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	2.05e-05	0.00086	CcSEcCtD
Orciprenaline—Asthenia—Prednisone—chronic obstructive pulmonary disease	2e-05	0.000837	CcSEcCtD
Orciprenaline—Pruritus—Prednisone—chronic obstructive pulmonary disease	1.97e-05	0.000826	CcSEcCtD
Orciprenaline—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	1.91e-05	0.000798	CcSEcCtD
Orciprenaline—Dizziness—Prednisone—chronic obstructive pulmonary disease	1.84e-05	0.000772	CcSEcCtD
Orciprenaline—Vomiting—Prednisone—chronic obstructive pulmonary disease	1.77e-05	0.000742	CcSEcCtD
Orciprenaline—Headache—Prednisone—chronic obstructive pulmonary disease	1.75e-05	0.000731	CcSEcCtD
Orciprenaline—Nausea—Prednisone—chronic obstructive pulmonary disease	1.66e-05	0.000693	CcSEcCtD
